
|
Report Date : |
20th June, 2006 |
|
Correct Name : |
DHANUKA
LABORATORIES LIMITED |
|
|
|
|
Formerly Known As : |
DHANUKA
LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered Office : |
861-862, Joshi Road, Karol
Bagh, New Delhi – 110005, India. |
|
|
|
|
Country : |
India
|
|
|
|
|
Financials (as on) : |
31.03.2005 |
|
|
|
|
Date of Incorporation : |
24.02.1993 |
|
|
|
|
Com. Reg. No.: |
55-52285 |
|
|
|
|
CIN No.: [Company Identification No.] |
U74999DL1993PLC052285 |
|
|
|
|
TAN No.: [Tax Deduction & Collection Account No.] |
DELD04043E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACD2877R |
|
|
|
|
Legal Form : |
A
Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers and Exporters
of Pharma Bulk Drugs and Intermediates. |
|
MIRA’s Rating : |
Ba |
RATING
|
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 325000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
established and reputed company having satisfactory fine track. Trade
relations are fair. Payments are correct and as per commitments. The company can be
considered good for any normal business dealings. It can be regarded as
promising business partner in a medium to long run. |
|
Registered Office : |
861-862, Joshi Road, Karol
Bagh, New Delhi – 110005, India. |
|
Tel. No.: |
91-11-23518981/ 23518982/
23518983 |
|
Fax No.: |
91-11-23516750 / 23518981 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Commercial
|
|
|
|
|
Head Office / Corporate Office : |
Dhanuka
Group, Dhanuka House, 861-862, Joshi Road, Karol Bagh, New Delhi- 110 005,
India |
|
Tel. No.: |
91-11-23519461 to
63/23518982/23518983/ 23518925/ 27534112 / 23518981/2/3 |
|
Fax No.: |
91-11-23518981/
23516750 |
|
E-Mail : |
|
|
|
|
|
Factory/ Warehouse : |
7KM,
Old Manesar Road, Village, Mohammed Pur, District – Gurgaon, Haryana, India. |
|
Tel. No.: |
91-124-2371884/
2372715 |
|
Fax No.: |
91-124-2371931 |
|
E-Mail : |
|
|
Area : |
3000
sq. meters |
|
Location : |
Owned
Industrial |
|
Name : |
Mr.
Arun Kumar Dhanuka |
|
Designation : |
Director
|
|
Address : |
4/31
– B, Rajpur Road, Civil Lines, Delhi - 110054 |
|
Date of Appointment : |
30.12.1994 |
|
|
|
|
Name : |
Ms.
Pushpa Dhanuka |
|
Designation : |
Director
|
|
Address : |
4/31
– B, Rajpur Road, Civil Lines, Delhi - 110054 |
|
Date of Appointment : |
21.09.1996 |
|
|
|
|
Name : |
Mr.
Manish Dhanuk |
|
Designation : |
Director
|
|
Address : |
4/31
– B, Rajpur Road, Civil Lines, Delhi - 110054 |
|
Date of Appointment : |
30.12.1994 |
|
|
|
|
Name : |
Ms.
Seema Dhanuka |
|
Designation : |
Director
|
|
Address : |
4/31
– B, Rajpur Road, Civil Lines, Delhi - 110054 |
|
Date of Appointment : |
21.09.1996 |
|
|
|
|
Name : |
Mr.
Mahendra Kumar Dhanuka |
|
Designation : |
Director
|
|
Address : |
95-B,
E-2, Lane, Estern Avenue, Sainik Farms, New Delhi - 110062 |
|
Date of Appointment : |
02.03.1999 |
|
|
|
|
Name : |
Mr.
Rahul Kumar Dhanuka |
|
Designation : |
Director |
|
Address : |
95-B,
E-2, Lane, Estern Avenue, Sainik Farms, New Delhi - 110062 |
|
Date of Appointment : |
02.03.1999 |
|
|
|
|
Name : |
Mr.
Harsh Kumar Dhanuka |
|
Designation : |
Director
|
|
Address : |
95-B,
E-2, Lane, Estern Avenue, Sainik Farms, New Delhi - 110062 |
|
Date of Appointment : |
24.10.2001 |
|
|
|
|
Name : |
Ms.
Urmila Dhanuka |
|
Designation : |
Director
|
|
Address : |
95-B,
E-2, Lane, Estern Avenue, Sainik Farms, New Delhi - 110062 |
|
Date of Appointment : |
24.10.2001 |
|
Name : |
Manoj
Mendirat |
|
Designation : |
Company
Secretary |
|
Address : |
112-C-2,
Mianwali Colony, Gurgaon |
|
|
|
|
Name : |
L
N Mishra |
|
Designation : |
Company
Secretary |
|
Address : |
1155/1
Dayanand Colony, Gurgaon |
|
Date of Birth : |
02.01.1969 |
|
Names of Shareholders |
|
No. of Shares |
|
Dhanuka Kumar Arun |
|
13550 |
|
Dhanuka Manish |
|
5440 |
|
Dhanuka lal Late Gobind |
|
410 |
|
Dhanuka Mamta |
|
9190 |
|
Dhanuka Seema |
|
3700 |
|
Arun Kumar Dhanuka – HUF |
|
1000 |
|
Duke Impex Private Limited |
|
9850 |
|
Growth Advertising and
Marketing Private Limited |
|
9750 |
|
Cosmo Components Private
Limited |
|
10200 |
|
Late Gobind Lal Dhanuka –
HUF |
|
10200 |
|
Liberty Sales Private
Limited |
|
12250 |
|
Dhanuka Pushpa |
|
27300 |
|
Manish Dhanuka – HUF |
|
3850 |
|
Exclusive Leasing and
Finance Limited |
|
12700 |
|
Hindon Mercantile Limited |
|
15800 |
|
Delco Investment Company
Limited |
|
2700 |
|
M K Farmers Investments
Limited |
|
7500 |
|
Gupta Dass Ghanshyam |
|
1000 |
|
Khowala Reema |
|
1000 |
|
Dhanuka Rahul |
|
4000 |
|
Agarwal Gopal Ram |
|
4250 |
|
Dhanuka Kumar Mahendra |
|
3250 |
|
Shree Krishna Khetan |
|
4000 |
|
Zoom Leasing and Finance
Company Limited |
|
19800 |
|
Dhanuka Megha |
|
1700 |
|
Shirewala Vimal |
|
10 |
|
Dhanuka Versha |
|
4400 |
|
Dhanuka Mahendra HUF |
|
7000 |
|
R G Agarwal HUF |
|
25800 |
|
Vinaj Khetan |
|
4500 |
|
Sikkum Agro Industrial
Limited |
|
2000 |
|
Rahul Dhanuka HUF |
|
15000 |
|
Yasaki Export Private
Limited |
|
15000 |
|
Rakesh Impex Private
Limited |
|
16000 |
|
Rasu Traders Private
Limited |
|
15000 |
|
A R Builores private
Limited |
|
15000 |
|
Smit Advertisers Private
limited |
|
16000 |
|
Kanika Advertisers Private
limited |
|
15000 |
|
Stir Cement Products
Private Limited |
|
15000 |
|
Suraj Advertisers Private
Limited |
|
15000 |
|
Unnati Steel Private
Limited |
|
15000 |
|
Sauagar Impex Private
Limited |
|
14000 |
|
T S Computers Private
Limited |
|
14000 |
|
T S Packing Private Limited
|
|
14000 |
|
Pushpanjali Export Private
Limited |
|
10000 |
|
Lotus Plantation Private
Limited |
|
10000 |
|
|
|
|
|
Line of Business : |
Manufacturers and Exporters
of Pharma Bulk Drugs and Intermediates. |
|
|
|
|
Products : |
Ř
Cephalexin Monohydrate
(IP/BP) Ř
Cefadroxil (IP/UBP) Ř
Cefaclor (USP) Ř
Cefixime Trihydrate Ř
Cefdinir Ř
Cefuroxime Proxetil Ř
7-Amino Desacetoxy
Cephalosporanic Acid Ř
Simvastatin (USP) Ř
Caldan 4G Ř
Caldan 50 SP Ř
Sheathmar Ř
Nukil Ř
Kasu-B Ř
Vitavax Ř
Dimilin Ř
Plantvax Ř
Targa Super Ř
Dhanusan Ř
Dhanvan Ř
Triumphcard Ř
Superkiller Ř
Dhanuvit Ř
Dhanzyme Liquid and
Granules Ř
Dhanulux |
|
|
|
|
Exports to : |
Singapore,
Thailand & HongKong |
|
|
|
|
Imports from : |
China,
Germany & HongKong |
|
|
|
|
Terms : |
|
|
Selling : |
Cash
or L/C or Credit upto 30/ 60 days terms |
|
|
|
|
Purchasing : |
L/C
or Credit upto 30/ 60 days terms |
|
Particulars |
Unit |
Installed
Capacity
|
Actual
Production
|
|
|
|
|
|
|
Cephalexin Mohohydrate |
Kgs. |
Compaign Based |
4657.37 |
|
Simvastatin |
Kgs. |
Compaign Based |
-- |
|
7- ADCA |
Kgs. |
Compaign Based |
5735.00 |
|
Cefixime |
Kgs. |
18000 |
15191.30 |
|
Cefaclor |
Kgs. |
12000 |
8216.50 |
|
SOPT |
Kgs. |
Compaign Based |
54120.00 |
|
Cefadroxil |
Kgs. |
Compaign Based |
18438.50 |
|
7-AVCA/ 7-ACCA |
Kgs. |
N A |
2867.00 |
|
Cefdinir |
Kgs. |
Compaign Based |
127.25 |
|
Cefpodoxime Proxitele |
Kgs. |
Compaign Based |
15.00 |
|
|
|
|
|
|
Suppliers : |
Ř
Alembic Limited,
Baroda, Gujarat Ř
Dauralla Organics
Limited, New Delhi, India Ř
Relaince Silicon
Limited, Mumbai Ř
DSM Gist BV, Holland. |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Customers : |
Wholesaler and Manufacturer Some of its major customers
are as under: Ř
Rajasthan Drugs &
Pharmaceuticals Limited, India Ř
RPG Life Sciences
Limited, Ankleshwar, Gujarat Ř
Goa Antibiotics
Limited, India Ř
Cadila Healthcare
Limited, Ahmedabad, Gujarat |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
No. of Employees : |
Around
100 |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Bankers : |
>
State Bank of
Hyderabad
Scope Complex,
Lodhi Road, New Delhi >
Indian Overseas Bank >
ANZ Grindlays Bank |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking Relations : |
Good
|
|
|
|
|
Auditors : |
Uttar
Pradesh office: Gupta
Garg and Agarwal Chartered
Accountants 307,
Ocean Plaza, Sector 18, Noida- 201 301, India Tel.
No. : 91-120-2510511/ 2514217 Fax
No. : 91-120-2514217 E-
Mail : gganoida@hotmail.com Delhi
Office: G-55
Royal Palace, Laxmi Nagar, Delhi- 110 092, India Tel.
No. : 91-11-22202455/ 22215914 |
|
|
|
|
Affiliates : |
Ř
Dhanuka Pesticides
Limited, India Ř
Northern Minerals
Limited, India |
|
|
|
|
Group Company : |
Ř
Growth Advertising and
Marketing Private Limited Ř
Liberty Sales Private
Limited Ř
Cosmo Components
Private Limited Ř
Duke Impex Private
Limited |
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
500000 |
Equity
Shares |
Rs. 100/- |
Rs. 50.000 million |
Issued, Subscribed
& Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
439000 |
Equity
Shares |
Rs. 100/- |
Rs. 43.900 million |
FINANCIAL
DATA
[all figures are in Rupees Millions]
|
SOURCES OF FUNDS |
31.03.2005 |
31.03.2004 |
31.03.2003 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
43.900 |
23.900 |
23.900 |
|
|
2] Reserves & Surplus |
41.231 |
29.165 |
22.722 |
|
NETWORTH
|
85.131 |
53.065 |
46.622 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
70.326 |
72.518 |
47.683 |
|
|
2] Unsecured Loans |
69.694 |
70.667 |
54.058 |
|
TOTAL
BORROWING
|
140.020 |
143.185 |
101.741 |
|
|
DEFERRED TAX LIABILITIES |
17.123 |
12.642 |
6.578 |
|
|
|
|
|
|
|
TOTAL
|
242.274 |
208.892 |
154.941 |
|
|
|
|
|
|
|
APPLICATION OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block]
|
92.516 |
77.514 |
68.154 |
|
INVESTMENTS
|
0.001 |
0.001 |
0.000 |
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES
|
|
|
|
|
|
|
Inventories
|
85.174
|
57.219
|
74.032
|
|
|
Sundry Debtors
|
116.171
|
128.355
|
71.030
|
|
|
Cash & Bank Balances
|
11.373
|
18.351
|
10.915
|
|
|
Other Current Assets
|
0.000
|
0.000
|
0.000
|
|
|
Loans & Advances
|
48.591
|
27.753
|
30.732
|
Total Current Assets
|
261.309
|
231.678 |
186.709
|
|
Less : CURRENT LIABILITIES & PROVISIONS
|
|
|
|
|
|
|
Current Liabilities
|
109.527
|
99.629
|
101.023
|
|
|
Provisions
|
3.100
|
2.200
|
1.100
|
Total Current Liabilities
|
112.627
|
101.829 |
102.123
|
|
Net Current
Assets
|
148.682
|
129.849 |
84.586
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES
|
1.075 |
1.528 |
2.201 |
|
|
|
|
|
|
|
TOTAL
|
242.274 |
208.892 |
154.941 |
|
|
PARTICULARS |
31.03.2005 |
31.03.2004 |
31.03.2003 |
Sales Turnover [including other income]
|
609.186 |
539.783 |
547.901 |
|
|
|
|
|
Profit/(Loss) Before Tax
|
19.954 |
15.000 |
13.607 |
Provision for Taxation
|
7.888 |
8.557 |
3.677 |
Profit/(Loss) After Tax
|
12.066 |
6.443 |
9.930 |
|
|
|
|
|
Export Value
|
201.026 |
162.101 |
83.347 |
|
|
|
|
|
Import Value
|
229.599 |
220.981 |
196.372 |
|
|
|
|
|
Total Expenditure
|
584.756 |
521.091 |
531.733 |
|
PARTICULARS |
|
31.03.2005 |
31.03.2004 |
31.03.2003 |
PAT / Total Income
|
(%)
|
1.98 |
1.19 |
1.81
|
|
|
|
|
|
|
Net Profit Margin
(PBT/Sales) |
(%) |
3.27 |
2.78 |
2.48
|
|
|
|
|
|
|
Return on Total Assets
(PBT/Total Assets} |
(%) |
5.64 |
4.85 |
5.29
|
|
|
|
|
|
|
Return on Investment (ROI)
(PBT/Networth) |
|
0.23 |
0.218 |
0.29
|
|
|
|
|
|
|
Debt Equity Ratio
(Total Liability/Networth) |
|
2.96 |
4.62 |
4.37
|
|
|
|
|
|
|
Current Ratio
(Current Asset/Current
Liability) |
|
2.32 |
2.28 |
1.83
|
Fixed Assets
v
Air conditioner
v
Building
v
Cellular Phone
v
Computer
v
Electric and Instruments
v
Fore Fighting Equipments
v
Furniture and Fixture
v
Lab Equipments
v
Land
v
Office Equipments
v
Plant and machinery
v
Steel Structure
v
Vehicles
v
Commercial Vehicles
v
Effluent Treatment Plant
Operations and Financial Highlights
The members would be pleased to note that the company has been able to surpass the target and achieved a turnover of Rs. 640.859 millions. During this period the company has exported goods worth Rs. 200.156 millions directly, which is almost 25 % higher than previous year. The profit during this period is Rs. 12.066 millions after providing for interest, income Tax and depreciation, which is almost double than the previous year. The company has made provision for the tax amounting to Rs. 3.100 millions and also made a provision for deferred tax amounting to Rs. 4.480 millions.
The
company has continued to produce high quality goods and they are pleased to
inform that the company is supplying products to most of the premium
pharmaceutical companies in India. The company has achieved a significant
market for cefixime in the domestic as well in the international market. The
new product coachwork and its quality was well accepted by t he overseas
customers, sale and production of this product is increased by almost 265 %.
Further the capacity utilization of cefixime and cefachlor were also extremely
satisfactory.
Future Prospects
The company is planning to diversify into new and latest product based on the strength of R and D. Also company plans an expansion to increase the capacity. Further improvement in production facility to cater to regulated market like Europe are planned, which wil improve bottom line of the company. Their efforts will concentrate upon broadening of the customer base and product base.
About Group
The Dhanuka Group is a manufacturer/ formulator of a wide range of popular pesticides in Ecs, Granules, Wettables and Dust Formulations of Insecticides, Fungicides, Weedicides, PGR, Growth Stimulant and Wetting Agents. The group has emerge as a leading and growing Indian group in pesticides business with conventional as well as diversified interests.
Northern
Minerals Limited (NML), a flagship company of Dhanuka Group, was acquired as
sick unit in 1980 with a meager sales turnover of 17 million INR, is today a
unit of over 900 million INR.
They
have countrywide distribution network of distributors, preferred dealers and
retailers (over 8000), supported by our branch offices in all major states and
by our own marketing/ development staff, techno-commercially qualified and
trained and based on all India network.
The
Group has 23 branches, nearly 750 permanent employees of which 235 in marketing
organization. In addition, approximately 450-500 Technical Trainees are also
supporting marketing and customer service areas, especially right use
technology to the growers and vendors.
Group Companies
Name
of the Company : Dhanuka Pesticides Limited
Legal
Status : Public Limited
Company
Date
of Incorporation : 13th
February, 1985
Line
of Business : The Company is
manufacturing technical grade pesticides namely
Fenvalerate and Cypermethrin.
Production
Unit : Vill, Atta, Sohna
Mandkola Road, Tehsil Nuh, District Gurgaon,
Haryana,
India
Technical
Tie-up : E. I. DuPont De Nemours
and Company Inc., USA
Takeda Chemicals Industries Limited, Japan
for Cartap Hydrochloride
and
Validamycin
Mitsui
Chemicals Inc., Japan for Etofenprox
Hokko Chemicals Industries Company
Limited, Japan for
Kasugamycin.
Name
of the Company : Northon Minerals Limited
Legal
Status : Closely Held
Public Limited Company
Date
of Incorporation : 4th
August, 1960
Production
Unit : Daultabad Road, Gurgaon-
122 001, Haryana, India
Name
of the Company : Rajasthan Insecticides and Fertilizer Company Private
Limited
Legal
Status : Private Limited
Company
Date
of Incorporation : 17th
April, 1985
Porduction
Unit : A 64-65, Industrial Area,
Mandideep, District Raisen, Madhya Pradesh,
India
About
Company : In the year 1992
Group acquired another sick unit namely Rajasthan
Insecticides and Fertilizers Company Private Limited, mainly to make
dust
formulations. This unit has crossed 10,000 MTs production in the
3rd
year itself.
In 1984
their Group established a R and D unit maned Dhanuka
Agricultural Research Centre, to carry out in-house field research in
process
development. It is recoginsed by Ministry of Science and
Technology, Government of India.
Cartap
and Etofenprox were already in India market for over five years
without
making any imprint. Dhanuka in the first year itself sold 1635
MT of
Cartap Granules (Caldan4G), which in the third years has
crossed
the mark of 4050 MT. Etofenprox (NUKIL 10 EC) in the first
year was 87 KL. Similarly
Validamycin (Sheathmar 3L), a new molocule
in the
first year itself touch the mark of 60 KL.Kasugamycin (Kasu-B)
is launched
in the market in the year 2000 only.
On the
hand Northern Minerals Limited joined hands technically with
Uniroyal
Chemical Company Inc., USA in the year 1999 to formulate
and market Carboxin (Vitavax 75
WP), Oxycarboxin (Plantvax 20 EC)
and
Diflubenzuron (Dimilin 25 WP). We are in advance negotiation
stage for
further MOUs with few other MNCs.
Awards and Recognition
Ř
Institute of Trade and
Industrial Development Award for Quality Excellence in 1992. the prestigious
awards was presented to Mr. R. G. Agarwal, the Managing Director, Northern
Minerals Limited by Mr. Pranab Mukherjee, Honerable Minister of Commerce,
Government of India, on the occasion of the National Seminar on Quality
Consciousness, organized by the institute of 18th December, 1993.
Ř
Institute of Trade and
Industrial Development Swatantrata Swarn Jayanti Udyog Vibhushan Award for Excellence in Industrial Performance
was conferred on Mr. R. G. Agarwal on 27th January, 1999.
Ř
Indira Gandhi
Priyadarshani Award-1992, was presented to Mr. M. K. Dhanuka, Managing Directo,
Dhanuka Pesticides Limited for outstanding achievements and contribution on 76th
Birth Anniversary of Smt. Indira Gandhi by Mr. K. C. Pant, Chairman, Planning
Commission on 18th November, 1992 at New Delhi.
Ř
Yuva Ratan Award-1992,
was presented to Mr. M. K. Dhanuka, Managing Director, Dhanuka Pesticides
Limited by All India Youth Congress on 6th October, 1992 at New
Delhi.
Ř
Udyog Ratan Award was
conferred upon Mr. M. K. Dhanuka, Managing Director, Dhanuka Pesticides Limited
at the time of the conference on Econimic Development by Institute of Economic
Studies.
Ř
A award was conferred
upon Mr. M. K. Dhanuka, Managing Director, Dhanuka Pesticides Limited by Lions
Club for rendering invaluable support and co-operation of lionistic activities
during 1998-99.
Ř
Mr. R. G. Agarwal has
been nominated for ITID Rajat Jayanti Udyog Award, 2000.
|
Name of the company |
DHANUKA LABORATORIES PRIVATE LIMITED |
||||||||||||||||
|
Presented By |
DHANUKA LABORATORIES PRIVATE LIMITED |
||||||||||||||||
|
1) Date and description of
instrument creating the change |
Loan agreement deed of
hypothecation general condition dated 04.11.1997 and additional loan
agreement, deed of hypothecation general condition dated 04.01.2000 and deed
of hypothecation dated 11.06.2002 executed by DHANUKA LABORATORIES
PRIVATE LIMITED charge registered on
15.01.1998, 14.01.2000 and 04.07.2002 |
||||||||||||||||
|
2) Amount secured by the
charge/amount owing on the securities of charge |
Rs. 12.700 millions |
||||||||||||||||
|
3) Short particular of the
property charged. If the property acquired is subject to charge, date of the
acquired of the property should be given |
Registered charge on plot
of land measuring 2 Kanals having Khewal Khata no. 243/347-348. Killa No.
41/17/2 (2-0) and land measuring 01 Kanals 04 Matias Having khewat No.
41/17/3 ()1-4 total land measuring 3 Kanals 4 Matias and land measuring 1 Kanals
3 matias bearing Killa No. 17-31-2 (0-8). 3/2 (0-15) all land situated at
Village Mohmadpur Jharsa, Tehsil and Distt, Gurgaon with factory building
constructed thereon and machinery installed therein described in Schedule VI
and I to the loan agreement, deed of Hypothecation, General condition dated
04.11.97 , 04.01.2000 and 11.06.2002 goodwill and other present and future
assets as detailed in the said indentures. |
||||||||||||||||
|
4) Gist of the terms and
conditions and extent and operation of the charge. |
The principal sum of Rs.
25.335 millions to be repaid as per schedule of repayment of the aforesaid
loan agreement, deed of
hypothecation, general condition dated 04.11.1997 , 04.01.2000 and 11.06.2002
along with interest as mentioned in the said indenture. |
||||||||||||||||
|
5) Name and Address and
description of the person entitled to the charge. |
Haryana Financial Corporation 17.18 and 19 Sector
– 17A, Chandigarh |
||||||||||||||||
|
6) Date and brief description of instrument
modifying the charge |
Tripartite agreement dated
28.10.2002 between Haryana financial corporation, DHANUKA LABORATORIES
PRIVATE LIMITED and State bank of Hyderabad and Indian oversea Bank,
evidencing extension of second charge in favour of consortium of banks viz.
State Bank of Hyderabad and Indian Overseas Bank. |
||||||||||||||||
|
7) Particulars of
modifications specifying the terms and conditions or the extent of operations
of the charge in which modification is made and the details of the
modification. |
Limits granted by
consortium of Banks viz. State Bank of Hyderabad and India Overseas Bank
together with interest is now also secured by extension of second charge on
all present and future fixed assets of the company situated at 7 KM Stone,
Old Master Road, Village Mohammedpur, Gurgaon.
|
||||||||||||||||
|
|
|
||||||||||||||||
|
Name of the company |
DHANUKA LABORATORIES LIMITED |
||||||||||||||||
|
Presented By |
Company and State bank of Hyderabad |
||||||||||||||||
|
1) Date and description of
instrument creating the change |
Hypothecation agreement for
goods and assets dated 09.08.2004 |
||||||||||||||||
|
2) Amount secured by the
charge/amount owing on the securities of charge |
Rs. 5.300 millions |
||||||||||||||||
|
3) Short particular of the
property charged. If the property acquired is subject to charge, date of the
acquired of the property should be given |
All present and Future
goods, consumable spares, stores book debts and all other movable assets
of the borrower including documents
of title to the goods. Outstanding, monies, receivables including receivable
by way of cash incentive / cash assistance under the cash incentive scheme or
any way of refund of excise / custom duties under the duty draw back credit
scheme or any other schema bills, invoice investments and right and the
present machinery listed in the schedule hereunto and all future machinery
belonging to or in the possession or under the control of the Borrower or of
the bank or of any thirds party whether in India or wherever else thought the
world (including all such goods, other movable assets as may be in course of
shipment transit or delivery )
(hereinafter referred to as the said god and assets) shall stand
hypothecated to the Bank by way of first charge. |
||||||||||||||||
|
4) Gist of the terms and
conditions and extent and operation of the charge. |
Rate of interest @ 12.75 %
p.a. or as may be determined by the Bank from time to time. Repayable in 7 Quarterly
installments of Rs. 0.753 millions each w.e.f. 30.09.2004 |
||||||||||||||||
|
5) Name and Address and
description of the person entitled to the charge. |
State bank of Hyderabad Scope Complex., Lodhi Road, New Delhi |
||||||||||||||||
|
6) Date and brief description of instrument
modifying the charge |
No instrument was executed.
Letter evidencing deposit of title deeds to create equitable mortgage dated
16.02.2005 |
||||||||||||||||
|
7) Particulars of
modifications specifying the terms and conditions or the extent of operations
of the charge in which modification is made and the details of the
modification. |
Term Loan of Rs. 5.300
millions together with interest, costs and expenses etc. shall now be also
secured by equitable mortgage by first charge by deposit of title deeds in
respect of the company’s immovable property bearing Musttil No. 41, Killa NO.
17/3/1/2 (0-8), Killa No 17/3/2 (0-15), consisting of an Area of 1 Kannal and
3 Mahammadpur, Kharsa, Tehsil and Distt. Gurgaon together with all building
and structure thereon or to be thereon. |
CMT REPORT [Corruption, Money laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal Records
No available information exist that suggest that
subject or any of its principals have been formally charged or convicted by a
competent governmental authority for any financial crime or under any formal
investigation by a competent government authority for any violation of anti-corruption
laws or international anti-money laundering laws or standard.
8] Affiliation with Government :
No record exists to suggest that any director or
indirect owners, controlling shareholders, director, officer or employee of the
company is a government official or a family member or close business associate
of a Government official.
9] Compensation Package :
Our market survey revealed that the amount of
compensation sought by the subject is fair and reasonable and comparable to
compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs. 46.01 |
|
UK
Pound |
1 |
Rs. 84.93 |
|
Euro |
1 |
Rs. 58.30 |
SCORE
& RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP
CAPITAL |
1~10 |
6 |
|
OPERATING
SCALE |
1~10 |
6 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS
SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT
LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT
POINTS |
|
|
|
--BANK
CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER
ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT
POINTS |
|
|
|
--SOLE
DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT
ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER
MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
54 |
This score serves as a reference to assess SC’s credit risk and to set
the amount of credit to be extended. It is calculated from a composite of
weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial condition (40%) Ownership background (20%) Payment record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses
an extremely sound financial base with the strongest capability for timely
payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses
adequate working capital. No caution needed for credit transaction. It has
above average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial
& operational base are regarded healthy. General unfavourable factors
will not cause fatal effect. Satisfactory capability for payment of interest
and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable
& favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse
factors are apparent. Repayment of interest and principal sums in default or
expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute
credit risk exists. Caution needed to be exercised |
Credit not recommended |